Covered recipient · General Payments record
RAJESH THIRAVIAM PILLAI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,822.21
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $578.49 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $159.92 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $137.97 | 1 |
| Amgen Inc. | $68.44 | 4 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $52.39 | 2 |
| Medtronic, Inc. | $44.48 | 1 |
| PFIZER INC. | $44.26 | 2 |
| Novo Nordisk AS | $22.38 | 1 |
| INTRA-SANA LABORATORIES | $18.46 | 1 |
| GlaxoSmithKline, LLC. | $15.87 | 1 |
| Seqirus USA Inc | $14.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $14.26 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142290265 | CMS |
| ABIOMED | $145.66 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142290377 | CMS |
| Amgen Inc. | $16.31 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116176068 | CMS |
| Amgen Inc. | $18.90 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116176074 | CMS |
| Amgen Inc. | $14.36 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116176080 | CMS |
| Amgen Inc. | $18.87 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116176088 | CMS |
| Boston Scientific Corporation | $137.97 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092669635 | CMS |
| GlaxoSmithKline, LLC. | $15.87 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116521966 | CMS |
| Intra-Sana Laboratories | $18.46 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138620362 | CMS |
| Medtronic, Inc. | $44.48 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119444571 | CMS |
| Novo Nordisk Inc | $22.38 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096570942 | CMS |
| PFIZER INC. | $20.21 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132008543 | CMS |
| PFIZER INC. | $24.05 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132039522 | CMS |
| Seqirus USA Inc | $14.32 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125629406 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $29.18 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080683430 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $23.21 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080683488 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.